Building Capacity in Biostatistics for Cardiovascular and Diabetes Trials
Author Information
Author(s): Thabane Lehana, Wells George, Cook Richard, Platt Robert, Pogue Janice, Pullenayegum Eleanor, Matthews David, McCready Tara, Devereaux Philip J, Cairns John A, Yusuf Salim
Primary Institution: McMaster University
Hypothesis
The CANNeCTIN program aims to enhance biostatistical capacity and methodological innovation in clinical trials for cardiovascular diseases and diabetes.
Conclusion
The CANNeCTIN initiative is successfully training young biostatisticians and improving methodologies in clinical trials.
Supporting Evidence
- The CANNeCTIN program has engaged more than 100 researchers from 19 universities.
- The initiative aims to develop young trialists to lead large clinical trials.
- Monthly videoconferences are held to discuss biostatistical and methodological issues.
Takeaway
This study is about a program that helps train people to analyze health studies better, especially for heart and diabetes problems.
Methodology
The program includes monthly videoconferences, presentations at meetings, and training for young statisticians.
Limitations
The study does not provide specific data on the effectiveness of the training or the outcomes of the trials.
Participant Demographics
The program involves over 100 researchers from 19 universities across Canada.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website